Abstract: TH-PO958
Sarcopenia in Patients on Hemodialysis in Brazil: Results of the SARC-HD Study
Session Information
- Physical Activity and Lifestyle in Kidney Diseases
October 24, 2024 | Location: Exhibit Hall, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Health Maintenance, Nutrition, and Metabolism
- 1500 Health Maintenance, Nutrition, and Metabolism
Authors
- Ribeiro, Heitor S., Universidade de Brasilia Faculdade de Ciencias da Saude, Brasilia, Federal District, Brazil
- Duarte, Marvery P., Universidade de Brasilia Faculdade de Ciencias da Saude, Brasilia, Federal District, Brazil
- Nobrega, Otavio, Universidade de Brasilia Faculdade de Ciencias da Saude, Brasilia, Federal District, Brazil
- Vieira, Fábio Augusto Silva, Universidade de Brasilia Faculdade de Ciencias da Saude, Brasilia, Federal District, Brazil
- Silva, Maryanne, Universidade Estadual Paulista Julio de Mesquita Filho, Botucatu, Brazil
- Mondini, Dário R., Universidade Estadual de Campinas, Campinas, SP, Brazil
- Maggi Sant'Helena, Bruna, Faculdade IELUSC, Joinville, SC, Brazil
- Disessa, Henrique Santos, Universidade Estadual Paulista Julio de Mesquita Filho, Bauru, Brazil
- Adamoli, Angélica Nickel, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
- Bundchen, Daiana C., Universidade Federal de Santa Catarina, Ararangua, Brazil
- Krug, Rodrigo de Rosso, Universidade de Cruz Alta, Cruz Alta, Brazil
- Inda-Filho, Antonio Jose, Centro Universitario ICESP, Brasilia, DF, Brazil
- Avesani, Carla Maria, Karolinska Institutet, Stockholm, Stockholm, Sweden
- Vogt, Barbara Perez, Universidade Federal de Uberlandia, Uberlandia, Brazil
- Reboredo, Maycon Moura, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil
Group or Team Name
- SARC-HD Study Group.
Background
Sarcopenia is a common feature of patients on hemodialysis and is strongly associated with adverse clinical outcomes, but its epidemiology in middle-income countries remains underexplored. We described the prevalence and risk factors for sarcopenia in patients on hemodialysis in Brazil.
Methods
Baseline data from the SARC-HD multicenter study was analyzed. Muscle strength was assessed by handgrip; muscle mass by calf circumference; and physical performance by gait speed. Sarcopenia diagnosis and staging were based on the revised EWGSOP2 as probable, confirmed, and severe sarcopenia. Prevalence rates were compared among clinical and sociodemographic characteristics and risk factors analyzed.
Results
983 patients (median 59 years; 40% female) from 19 Brazilian dialysis centers were enrolled. Prevalences of probable, confirmed, and severe sarcopenia were 12%, 9%, and 5%, respectively. The prevalence of sarcopenia increased with advancing age groups, ranging from 7% to 45% in males and from 4% to 21% in females. After adjustment for confounders, male sex (odds ratio [OR]:1.7, 95% confidence interval [CI]:1.1–2.7), older age (OR:3.4, 95%CI:2.2–5.4), white ethnicity (OR:1.8, 95%CI:1.2–2.8), hemodiafiltration treatment (OR:1.6, 95%CI:1.1–2.4), and catheter access (OR:1.6, 95%CI:1.0–2.4) were the main risk factor for sarcopenia; however, overweight (body mass index ≥25.0 kg/m2) was a protective factor (OR:0.3, 95%CI:0.2–0.4).
Conclusion
Any stage of sarcopenia was found in one out of four patients on hemodialysis. Male sex, older age, white ethnicity, hemodiafiltration treatment, and catheter access were risk factors for presenting sarcopenia. Our findings enhance the understanding of sarcopenia in patients on hemodialysis in Brazil.
Figure 1. Prevalence of sarcopenia stratified by age groups and sex.
Funding
- Government Support – Non-U.S.